QingSong Health Corporation (listed on HKEX, stock code 02661) reported simultaneous equity issuance and buy-back activities on 2 July 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange.
New shares from option exercises • Five batches of employee option exercises under the company’s Pre-IPO Share Option Scheme added a total of 1.78 million ordinary shares to the register, equal to 0.87% of the 204.33 million shares outstanding prior to the transactions. • Strike prices ranged widely—from HK$0.00078 to HK$7.41 per share—resulting in gross proceeds of roughly HK$5.46 million.
Share repurchase moved into treasury • On the same day, QingSong Health bought back 2.97 million shares on the Exchange at prices between HK$9.69 and HK$10.74, for an aggregate HK$29.89 million. • The repurchased stock, representing 1.45% of pre-transaction issued shares, is being held as treasury shares; no cancellations have yet been effected.
Updated share capital structure (as of 2 July 2026) • Issued shares outstanding (excluding treasury): 203.14 million, down 0.59% from 204.33 million. • Treasury shares: increased to 5.01 million from 2.04 million. • Total issued shares (including treasury): 208.15 million, up 0.86%.
Repurchase mandate utilisation • The 2.97 million shares bought represent 2.43% of the 122.15 million shares authorised for buyback under the mandate approved on 22 May 2026, leaving capacity to repurchase up to 17.67 million additional shares. • Under Hong Kong listing rules, QingSong Health cannot issue further new shares or dispose of treasury shares on-market until 1 August 2026, following the repurchase activity.
The company confirmed that all transactions were duly authorised, funds received, and conducted in compliance with Hong Kong Stock Exchange regulations and applicable laws.
Comments